Literature DB >> 24128801

Oral microbiota and systemic disease.

Purnima S Kumar1.   

Abstract

It is well known that bacteria are the primary cause of infectious diseases, however, evidence is emerging that these organisms are also indirectly responsible for several diseases including cancer and rheumatoid arthritis. The oral cavity is home to several million bacteria that can cause two major diseases-periodontitis and caries. The relationship between periodontopathic bacteria and systemic diseases has been explored for several years. The concept of the oral cavity as a source of distant infection has been debated for at least a century. This review will discuss the historic aspects of the development of the focal infection theory, the reasons for its demise, its re-emergence and current status.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Focal infection; Focal sepsis; Oral bacteria; Periodontal medicine; Systemic disease

Mesh:

Year:  2013        PMID: 24128801     DOI: 10.1016/j.anaerobe.2013.09.010

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  40 in total

1.  Significant aspects and correlation between glycemic control and generalized chronic periodontitis in type 2 diabetes mellitus patients.

Authors:  Manuela Stoicescu; Horea Calniceanu; Ioan Țig; Sebastian Nemeth; Adriana Tent; Adelina Popa; Ciprian Brisc; Ioana Ignat-Romanul
Journal:  Exp Ther Med       Date:  2021-04-23       Impact factor: 2.447

2.  In vivo and ex vivo actions of a novel P. gingivalis inhibitor on multi-species biofilm, inflammatory response, and periodontal bone loss.

Authors:  Meng-Hsuan Ho; Hatice Hasturk; Daphne F Young; Hua Xie
Journal:  Mol Oral Microbiol       Date:  2020-07-20       Impact factor: 3.563

3.  Association of periodontal disease with oral cancer: a meta-analysis.

Authors:  Qi-Wei Yao; Dong-Sheng Zhou; Hong-Juan Peng; Ping Ji; De-Sheng Liu
Journal:  Tumour Biol       Date:  2014-04-23

4.  Tannerella forsythia-produced methylglyoxal causes accumulation of advanced glycation endproducts to trigger cytokine secretion in human monocytes.

Authors:  R P Settem; K Honma; M Shankar; M Li; M LaMonte; D Xu; R J Genco; R W Browne; A Sharma
Journal:  Mol Oral Microbiol       Date:  2018-05-02       Impact factor: 3.563

5.  Filifactor alocis Promotes Neutrophil Degranulation and Chemotactic Activity.

Authors:  Cortney L Armstrong; Irina Miralda; Adam C Neff; Shifu Tian; Aruna Vashishta; Lisandra Perez; Junyi Le; Richard J Lamont; Silvia M Uriarte
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

6.  Comparison of inherently essential genes of Porphyromonas gingivalis identified in two transposon-sequencing libraries.

Authors:  J A Hutcherson; H Gogeneni; D Yoder-Himes; E L Hendrickson; M Hackett; M Whiteley; R J Lamont; D A Scott
Journal:  Mol Oral Microbiol       Date:  2015-10-23       Impact factor: 3.563

7.  Filifactor alocis modulates human neutrophil antimicrobial functional responses.

Authors:  Jacob S Edmisson; Shifu Tian; Cortney L Armstrong; Aruna Vashishta; Christopher K Klaes; Irina Miralda; Emeri Jimenez-Flores; Junyi Le; Qian Wang; Richard J Lamont; Silvia M Uriarte
Journal:  Cell Microbiol       Date:  2018-02-12       Impact factor: 3.715

8.  Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.

Authors:  Meng-Hsuan Ho; Richard J Lamont; Walter J Chazin; Huiqing Chen; Daphne F Young; Prashant Kumar; Hua Xie
Journal:  Mol Oral Microbiol       Date:  2018-10-30       Impact factor: 3.563

9.  Transcriptome analysis of Porphyromonas gingivalis and Acinetobacter baumannii in polymicrobial communities.

Authors:  D P Miller; Q Wang; A Weinberg; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2018-08-03       Impact factor: 3.563

Review 10.  The oral microbiota: dynamic communities and host interactions.

Authors:  Richard J Lamont; Hyun Koo; George Hajishengallis
Journal:  Nat Rev Microbiol       Date:  2018-12       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.